Financial News · Live Terminal

Page 284 of 352

Truist Adjusts Price Target on Carlisle to $360 From $340, Maintains Hold Rating

Carlisle (CSL) has an average rating of overweight and mean price target of $407.29, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $383.61, Change: $+19.75, Percent Change: +5.43%

$CSL

Wire62d ago

UBS Adjusts AGNC Investment Price Target to $11 From $10.50, Maintains Neutral Rating

AGNC Investment (AGNC) has an average rating of overweight and mean price target of $11.44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $10.84, Change: $-0.02, Percent Change: -0.18%

$AGNC

Wire62d ago

Truist Adjusts Price Target on Medpace to $462 From $539, Maintains Hold Rating

Medpace (MEDP) has an average rating of hold and mean price target of $457.45, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $391.52, Change: $-1.90, Percent Change: -0.48%

$MEDP

Wire62d ago

Truist Securities Adjusts Royal Caribbean Price Target to $318 From $327, Maintains Hold Rating

Royal Caribbean Group (RCL) has an average rating of overweight and mean price target of $350.61, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $259.80, Change: $-0.72, Percent Change: -0.28%

$RCL

Wire62d ago

Market Chatter: Organon Shares Rise Pre-Bell Amid Report of Sun Pharmaceutical's Proposed $13 Billion Bid

Organon (OGN) shares rose more than 7% in Friday's premarket activity amid a report that India's Sun Pharmaceutical Industries was planning a $13 billion bid for the company.Organon would merge with Sun Pharmaceutical if an agreement is reached, according to a report from the Economic Times. Sun Pharma is competing with other major players, the report added.Organon and Sun Pharmaceutical did not immediately respond to' requests for comment.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $9.28, Change: $+0.68, Percent Change: +7.89%

Financial News · Live Terminal

Truist Adjusts Price Target on Carlisle to $360 From $340, Maintains Hold Rating

UBS Adjusts AGNC Investment Price Target to $11 From $10.50, Maintains Neutral Rating

Truist Adjusts Price Target on Medpace to $462 From $539, Maintains Hold Rating

Truist Securities Adjusts Royal Caribbean Price Target to $318 From $327, Maintains Hold Rating

Market Chatter: Organon Shares Rise Pre-Bell Amid Report of Sun Pharmaceutical's Proposed $13 Billion Bid

Unico Silver Reduces Rigs at Argentina Drilling Operations During Transition to Winter Operations

Coursera Q1 Non-GAAP Earnings Fall, Revenue Rises; Shares Drop After Hours

MaxLinear Q1 Swings to Adjusted Earnings, Revenue Rises; Q2 Guidance Set

Glacier Bancorp Q1 Operating Earnings, Revenue Rise; Shares Drop After Hours

Erie Indemnity Q1 Earnings, Revenue Rise

Ameriprise Financial Q1 Adjusted Earnings, Revenue Rise

Robert Half Q1 Earnings, Revenue Fall

Hartford Insurance Group Q1 Core Earnings, Revenue Rise; Shares Fall After Hours

Intel Fiscal Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

GUIDANCE: (INTC) Intel Expects Q2 Revenue Range $13.8B-14.8B, vs. FactSet Est of $13.11B

Earnings Flash (INTC) Intel Posts Q1 Adjusted EPS $0.29

Earnings Flash (INTC) Intel Posts Q1 Revenue $13.6B, vs. FactSet Est of $12.42B

Top Cryptocurrencies Lower; Bitcoin Falls Below $78,000 Level

L3Harris Technologies Keeps Quarterly Dividend at $1.25 a Share, Payable June 26 to Holders of Record June 5

Ecopetrol to Buy 26% Stake in Brazil's Brava Energia

Truist Adjusts Price Target on Carlisle to $360 From $340, Maintains Hold Rating

UBS Adjusts AGNC Investment Price Target to $11 From $10.50, Maintains Neutral Rating

Truist Adjusts Price Target on Medpace to $462 From $539, Maintains Hold Rating

Truist Securities Adjusts Royal Caribbean Price Target to $318 From $327, Maintains Hold Rating

Market Chatter: Organon Shares Rise Pre-Bell Amid Report of Sun Pharmaceutical's Proposed $13 Billion Bid

Unico Silver Reduces Rigs at Argentina Drilling Operations During Transition to Winter Operations

Coursera Q1 Non-GAAP Earnings Fall, Revenue Rises; Shares Drop After Hours

MaxLinear Q1 Swings to Adjusted Earnings, Revenue Rises; Q2 Guidance Set

Glacier Bancorp Q1 Operating Earnings, Revenue Rise; Shares Drop After Hours

Erie Indemnity Q1 Earnings, Revenue Rise

Ameriprise Financial Q1 Adjusted Earnings, Revenue Rise

Robert Half Q1 Earnings, Revenue Fall

Hartford Insurance Group Q1 Core Earnings, Revenue Rise; Shares Fall After Hours

Intel Fiscal Q1 Adjusted Earnings, Revenue Rise; Q2 Guidance Set

GUIDANCE: (INTC) Intel Expects Q2 Revenue Range $13.8B-14.8B, vs. FactSet Est of $13.11B

Earnings Flash (INTC) Intel Posts Q1 Adjusted EPS $0.29

Earnings Flash (INTC) Intel Posts Q1 Revenue $13.6B, vs. FactSet Est of $12.42B

Top Cryptocurrencies Lower; Bitcoin Falls Below $78,000 Level

L3Harris Technologies Keeps Quarterly Dividend at $1.25 a Share, Payable June 26 to Holders of Record June 5

Ecopetrol to Buy 26% Stake in Brazil's Brava Energia